EAM Investors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
FAM
1WCM
EAM Investors's RGEN Position: Q1 2021 in Review
EAM Investors sold out of Repligen (RGEN) in Q1 2021, closing a stake of 7,191 shares — an estimated $1.38M sold.
EAM Investors first reported a position in RGEN in Q2 2013 and held it in 19 quarters. The position peaked at $3.74M in Q3 2018. 458 funds tracked by Wall St. Rank hold RGEN as of Q1 2021.
- EAM Investors reported no remaining Repligen position as of Q1 2021 after selling out during the quarter.
- EAM Investors sold 7,191 Repligen shares in Q1 2021, an estimated $1.38M.
- EAM Investors first reported a position in Repligen in Q2 2013 and held it in 19 quarters.
- EAM Investors's Repligen position peaked at $3.74M in Q3 2018.
- 458 funds tracked by Wall St. Rank held Repligen as of Q1 2021.
Based on EAM Investors's 13F filing for Q1 2021, filed 11 May 2021.